bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

bupropion hydrochloride 75 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-866
Product ID 71610-866_d103c1fe-4d4c-48e2-8e30-494b19dd7e52
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206975
Listing Expiration 2026-12-31
Marketing Start 2016-08-19

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610866
Hyphenated Format 71610-866

Supplemental Identifiers

RxCUI
993691
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA206975 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (71610-866-53)
  • 90 TABLET in 1 BOTTLE (71610-866-60)
  • 120 TABLET in 1 BOTTLE (71610-866-70)
  • 180 TABLET in 1 BOTTLE (71610-866-80)
source: ndc

Packages (4)

71610-866-53 60 TABLET in 1 BOTTLE (71610-866-53) 71610-866-60 90 TABLET in 1 BOTTLE (71610-866-60) 71610-866-70 120 TABLET in 1 BOTTLE (71610-866-70) 71610-866-80 180 TABLET in 1 BOTTLE (71610-866-80)

Ingredients (1)

bupropion hydrochloride (75 mg/1)

Linked Drug Pages (1)

bupropion Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d103c1fe-4d4c-48e2-8e30-494b19dd7e52", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993691"], "spl_set_id": ["d0eada89-e302-4ba3-bef0-e8c69af8206e"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-866-53)", "package_ndc": "71610-866-53", "marketing_start_date": "20241121"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-866-60)", "package_ndc": "71610-866-60", "marketing_start_date": "20241121"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-866-70)", "package_ndc": "71610-866-70", "marketing_start_date": "20241121"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-866-80)", "package_ndc": "71610-866-80", "marketing_start_date": "20241121"}], "brand_name": "bupropion Hydrochloride", "product_id": "71610-866_d103c1fe-4d4c-48e2-8e30-494b19dd7e52", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-866", "generic_name": "bupropion Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA206975", "marketing_category": "ANDA", "marketing_start_date": "20160819", "listing_expiration_date": "20261231"}